Vaxart

+$0.09 (+2.44%) Today
-$0.03 (-0.79%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxart and other ETFs, options, and stocks.

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection.

CEO
Andrei Floroiu
Employees
110
Headquarters
South San Francisco, California
Founded
2004

VXRT Key Statistics

Market cap
477.97M
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.62M
High today
$3.85
Low today
$3.55
Open price
$3.77
Volume
5.13M
52 Week high
$10.33
52 Week low
$2.49

VXRT Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure